INTRODUCTION

Top Abstract Introduction Materials & Methods Results Discussion References

Clostridium perfringens enterotoxin (CPE) is a 35-kDa single polypeptide that contributes to the pathogenesis of C. perfringens type A food poisoning, as well as several nonfoodborne human diarrheas (e.g., antibiotic-associated diarrhea) and gastrointestinal illnesses of domestic animals (1-3, 6, 13, 14, 22). The enteropathogenic effects of CPE are primarily mediated through a multistep cytotoxic action (13), which initiates when CPE binds to a proteinaceous receptor(s) (5, 7, 8, 16, 18, 24, 25). While the full repertoire of membrane proteins capable of serving as functional CPE receptors remains undetermined, recent expression cloning experiments (7, 8) have demonstrated that several homologues of the rat androgen withdrawal apoptosis protein RVP1 are functional CPE receptors. Further, a biochemical study (24) has suggested that an ~50-kDa CPE-binding membrane protein may also be a CPE receptor. Upon binding, CPE rapidly becomes localized in a small (~90-kDa) complex present in plasma membranes (24); at temperatures above 4°C, this small CPE complex then apparently associates with at least one additional membrane protein to form a large (160-kDa) complex (7, 15, 24, 26). Formation of this large complex coincides with the onset of CPE-induced small-molecule membrane permeability alterations (15), which (in turn) result in cell death from overt lysis or metabolic disruption (13).

Even though CPE apparently possesses a relatively modest initial binding affinity for cells or isolated membranes (16), reports indicate that, after binding, this toxin does not appreciably dissociate from either isolated membranes or intact cells (4, 15-17, 25). Further, agents (e.g., chaotropic salts or divalent cation chelators) known to release peripherally bound membrane proteins do not promote dissociation of bound CPE (16, 17). The irreversible nature of CPE binding cannot be explained by the internalization of CPE into the cytoplasm, since a subcellular localization study (23) indicated that CPE remains plasma membrane associated throughout its action. Further, this essentially irreversible CPE binding does not correspond to large-complex formation, since CPE reportedly also does not dissociate appreciably at 4°C (16), a temperature where large-complex formation is sharply inhibited (15).

Nearly 20 years ago, McDonel reported that specifically bound CPE exhibits resistance to pronase-induced release from membranes (17), even though both CPE and the CPE receptor are highly sensitive to pronase (16, 17). McDonel hypothesized that this resistance of bound CPE to pronase-induced release from membranes reflects protection of CPE due to the insertion of this toxin into the lipid bilayers of plasma membranes and proposed that this insertion event explains why CPE does not dissociate after binding. Since CPE bound at 4°C also reportedly develops resistance to pronase-induced release from membranes (15), McDonel's hypothesis implies that membrane insertion occurs when CPE is sequestered in small complex. This hypothesis has enjoyed wide acceptance because insertion is known to contribute to the action of several other bacterial toxins that disrupt plasma membrane permeability properties (20).

However, an antibody probe study (9) of CPE-containing membranes has recently shown that, whether CPE is localized in small or large complex, at least a portion of the enterotoxin molecule remains exposed on the external surfaces of mammalian plasma membranes. Since at least a portion of CPE remains exposed on the membrane surface even under conditions where CPE is reportedly resistant to pronase-induced release from membranes, these recent antibody probe findings appear to be in some conflict with the hypothesis that, when it is sequestered in the small complex, CPE becomes resistant to pronase-induced release from membranes due to the insertion of this toxin into lipid bilayers. To address the apparent conflict between these antibody probe results and the CPE small-complex insertion hypothesis, the present study has carefully characterized the effects of pronase treatment of rabbit intestinal brush border membranes (BBMs) containing CPE localized in either small complex or large complex.

	MATERIALS AND METHODS

Top Abstract Introduction Materials & Methods Results Discussion References

Materials. CPE was prepared and purified, and its biologic activity was assayed as described previously (19). Purified CPE was radiolabeled as described previously (16) with lactoperoxidase-glucose oxidase (Bio-Rad) and 2 mCi of Na¹²⁵I (17 mCi/mg; ICN Radiochemicals). The specific radioactivity of ¹²⁵I-CPE was 1 to 3 mCi/mg of protein. Rabbit intestinal BBMs were prepared from the small intestines of female New Zealand White rabbits (2 to 4 kg each) by the method of Sigrist et al. (21). Pronase was purchased from Boehringer Mannheim; antipain, chymostatin, leupeptin, pepstatin, phenylmethylsulfonyl fluoride, dimethyl sulfoxide, EDTA, and Azocoll (Azo dye-impregnated collagen) were purchased from Sigma; and AEBSF [4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride] was obtained from ICN Biomedicals.

Binding of ¹²⁵I-CPE to intact BBMs. BBMs (100 µg) were gently shaken for 5 min at 4°C or room temperature (RT) in 100 µl of DPBS (140 mM NaCl, 2.7 mM KCl, 9 mM Na₂HPO₄, 1.5 mM KH₂PO₄ [pH 7.4]) containing 1.5 µg of ¹²⁵I-CPE in the presence or absence of a 50-fold excess of unlabeled CPE. As described previously (15, 16, 24), specific binding of ¹²⁵I-CPE was calculated by subtracting the radioactive counts associated with BBMs that had been cotreated with excess unlabeled CPE (nonspecific binding) from the radioactive counts associated with BBMs that had been treated only with ¹²⁵I-CPE (total binding). Specific binding was ~10⁵ cpm/sample and represented ~80% of the total bound radioactivity.

Optimization of pronase inhibition conditions. Prior to characterization of the ¹²⁵I-CPE-containing complexes remaining in pronase-treated BBMs (see below), it was first necessary to develop conditions that would stop proteolysis at the termination of the desired pronase treatment period, i.e., to stop proteolysis when the ¹²⁵I-CPE-containing complexes were still present in pronase-treated BBMs, so that no further degradation of these complexes would occur during detergent extraction or electrophoresis. To optimize conditions for stopping pronase activity, 100 µg of BBMs was treated at 4°C with 300 µg of freshly prepared pronase and these BBMs were then washed with DPBS, with or without various concentrations of protease inhibitors, zero to three times before being extracted with cold DPBS containing 1% Triton X-100, with or without various concentrations of protease inhibitors. Free ¹²⁵I-CPE was then added to each sample during extraction, and the extracted samples were boiled, electrophoresed by denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiographed. These experiments indicated that, when they were present during detergent extraction and three washes, 500 µg of antipain per ml, 20 µg of aprotinin per ml, 600 µg of chymostatin per ml, 5 mg of EDTA per ml, 5 µg of leupeptin per ml, 10 mg of AEBSF per ml, 7 µg of pepstatin per ml, and 2 mM phenylmethylsulfonyl fluoride prevented any significant degradation of free ¹²⁵I-CPE (data not shown). Consequently, this combination of protease inhibitors was employed throughout this study to stop proteolysis after the conclusion of the desired pronase treatment period.

Pronase treatment of ¹²⁵I-CPE-containing BBMs. BBMs containing ¹²⁵I-CPE bound at 4°C or RT were prepared as described above, washed once with cold DPBS, and resuspended in 50 µl of cold DPBS containing 300 µg of freshly prepared pronase. These BBMs were treated with pronase for 5 min or 1 h (as specified in the figures) at 4°C and then microcentrifuged. The radioactivity of the pellets was then either directly counted in a gamma counter (unwashed samples) or counted after the pellets were washed three times with 100 µl of cold DPBS containing the optimal concentrations of protease inhibitors (as stated above) (washed samples).

Pronase treatment of control BBMs. In some experiments, BBMs (100 µg) that had never been exposed to ¹²⁵I-CPE were washed with cold DPBS and treated for 5 min or 1 h at 4°C in 50 µl of cold DPBS containing 300 µg of freshly prepared pronase. After this pronase treatment, the BBMs were washed three times with 100 µl of cold DPBS (containing protease inhibitors) before being extracted with 100 µl of cold DPBS containing both 1% Triton X-100 and our standard combination of protease inhibitors. These extracts were analyzed by denaturing SDS-PAGE.

Analytical PAGE of samples. Some samples of washed pronase-treated BBMs containing ¹²⁵I-CPE bound at either 4°C or RT were analyzed by PAGE (as described below). These BBMs were prepared, pronase treated, and washed as described above and then extracted at 4°C with 100 µl of cold DPBS containing both 1% Triton X-100 and the same concentrations of protease inhibitors that were used for washing. The radioactivity of these membrane extracts was then counted in a gamma counter prior to electrophoresis (as specified below). Wash samples were also collected and their radioactivity was counted in a gamma counter, and then the samples were frozen and lyophilized for later electrophoretic analysis.

Preparative electrophoresis of small- and large-complex samples. BBMs (5 mg) were incubated (with gentle shaking) for 5 min, at either 4°C or RT, in 5 ml of DPBS with 15 µg of ¹²⁵I-CPE. These BBMs were then washed with cold DPBS, resuspended in cold DPBS, and incubated at 4°C for 5 min or 1 h in 2.5 ml of cold DPBS containing 3 mg of freshly prepared pronase. After three washes at 4°C with cold DPBS (containing our standard combination of protease inhibitors), the washed BBMs were extracted with 2.5 ml of cold DPBS containing both 1% Triton X-100 and our standard combination of protease inhibitors. Some BBMs containing bound ¹²⁵I-CPE were extracted with 1% Triton X-100 in cold DPBS (but without protease inhibitors) prior to the pronase treatment described above. After completion of this pronase treatment, protease inhibitors were added to these samples at the same final concentrations used in other experiments.

Azocoll assay. The Azocoll colorimetric assay was used to compare the proteolytic activity of freshly prepared pronase solution (300 µg/50 µl) with that of the same pronase solution after it had been used to treat BBMs. In this assay, 50 mg of Azocoll was incubated with an aliquot of pronase solution for 15 min at 37°C in 5 ml of DPBS. The nondigested collagen was then pelleted, and the remaining supernatant was used to measure A₅₂₀.

Other methods. Protein determinations were by the method of Lowry et al. (12), with bovine serum albumin as the protein standard. Radioactivity in samples containing ¹²⁵I was quantitated with a Packard gamma counter. Densitometric scans of autoradiographs and gels were performed with a ScanJet Plus (Hewlett-Packard) with the DeskScan II, version 2.3, program, and peak-area integrations were determined with the 1-D Process & Report program (Zeineh Biomedical Instruments).

	RESULTS

Top Abstract Introduction Materials & Methods Results Discussion References

Washing increases pronase-induced release of specifically bound ¹²⁵I-CPE from BBMs. This study initially reevaluated previous reports (4, 15-17) indicating that, at either 4°C or warmer temperatures, CPE binding is essentially irreversible. Surprisingly, our experiments revealed (Fig. 1A) that about 25% of specifically bound radioactivity does spontaneously dissociate (i.e., dissociate in the absence of washing) in the first five minutes after ¹²⁵I-CPE binding at 4°C. However, the remaining 75% of specifically bound radioactivity present in these samples was still membrane associated after 60 min of incubation at 4°C. Further, extensively washing BBMs containing ¹²⁵I-CPE bound at 4°C only slightly (~10%) increased the release of specifically bound radioactivity throughout the 1-h incubation period of this experiment (Fig. 1A).

View larger version (12K): [in this window] [in a new window]   FIG. 1.   Effects of washing BBMs on pronase-induced release of specifically bound 125I-CPE. 125I-CPE was bound to BBMs at 4°C (A) or at RT (B) in the presence or absence of excess unlabeled CPE. After unbound 125I-CPE was removed, the BBMs were incubated at 4°C with or without pronase (300 µg) for 5 min to 1 h. Circles, specifically bound radioactivity remaining in these pronase-treated BBMs; squares, specifically bound radioactivity remaining in the non-pronase-treated BBMs. After this pronase treatment, BBMs were pelleted and then their radioactivity was either directly counted in a gamma counter (nonwashed samples [open symbols]) or counted after the pellets were washed three times with cold DPBS containing protease inhibitors (see the text) (washed samples [filled symbols]). Values are means ± standard errors of the means. Error bars not shown indicate that the values were too small to depict. Each experiment was repeated three times with triplicate samples.

Effects of washing on the recovery of BBM proteins. The ability of washing to increase the release of specifically bound radioactivity from pronase-treated BBMs containing ¹²⁵I-CPE, as shown in Fig. 1, could indicate that either (i) specifically bound radioactivity becomes more loosely membrane associated after pronase treatment (suggesting that this radioactivity may be affected by pronase) or that (ii) extensive washing sharply decreases the recovery of pronase-treated BBMs, which would cause a nonspecific decrease in the recovery of all proteins (including ¹²⁵I-CPE) present in BBMs before pronase treatment. To discriminate between these two possibilities, we performed an experiment in which pronase-treated BBMs, with or without bound CPE, were washed three times with DPBS (containing our standard combination of protease inhibitors), extracted with 1% Triton X-100, electrophoresed by denaturing SDS-PAGE with sample boiling, and stained with Coomassie brilliant blue (Fig. 2). Densitometric scanning of gels from seven independent repetitions of this experiment (a representative gel is shown in Fig. 2) indicated that, relative to the recovery of washed BBMs processed similarly except for the omission of pronase treatment, 77% ± 6% of total BBM proteins were recovered from BBMs treated for 5 min with pronase before being washed and 71% ± 6% of the total BBM proteins were recovered from membranes treated for 1 h with pronase before being washed. Recovery of total BBM proteins from either pronase-treated BBMs or non-pronase-treated BBMs, whether washed or unwashed, was unaffected (data not shown) by the presence of CPE, whether this toxin had been bound at 4°C or RT. These results indicate that loss of total BBM proteins during washing cannot account for all of the washing-induced increase in the release of specifically bound CPE from pronase-treated BBMs that was observed in the experiments whose results are shown in Fig. 1.

View larger version (34K): [in this window] [in a new window]   FIG. 2.   Effect of washing on recovery of BBM proteins. BBMs were treated at 4°C with pronase (300 µg) and washed with cold DPBS (containing protease inhibitors; see Materials and Methods). These washed BBMs were extracted at 4°C with 1% Triton X-100, boiled, and electrophoresed on an SDS-10% polyacrylamide gel. The gel was then stained with Coomassie brilliant blue R-250. First lane, third molecular mass (Mr) markers; second lane, washed BBMs not treated with pronase (control); third lane, washed BBMs treated for 5 min with pronase; fourth lane, washed BBMs treated for 1 h with pronase. The gel shown in this figure is representative of gels used in seven repetitions of this experiment.

Electrophoretic analysis of pronase-treated ¹²⁵I-CPE bound to BBMs at 4°C. Before we analyzed whether CPE bound to BBMs at 4°C is affected by pronase, it was important to first confirm that the CPE present in these BBMs is localized in small complex. When BBMs containing ¹²⁵I-CPE bound at 4°C were washed three times with DPBS, extracted with 1% Triton X-100, and analyzed (Fig. 3, lane 4) by native PAGE (24), virtually all of the specifically bound ¹²⁵I-CPE in these samples was clearly localized in small complex. This result is fully consistent with previous reports (9, 15) indicating that little or no large complex forms at this low temperature. Further, native PAGE analysis of the washes collected from these non-pronase-treated BBMs showed (Fig. 3, lane 6) that there is little or no spontaneous dissociation of small complex from these BBMs. This observation is fully consistent with the Fig. 1A results indicating that, 5 min after binding at 4°C, there is only limited spontaneous dissociation of ¹²⁵I-CPE from BBMs.

View larger version (42K): [in this window] [in a new window]   FIG. 3.   Native PAGE analysis of pronase-treated 125I-CPE bound to BBMs at 4°C. 125I-CPE was bound at 4°C to BBMs in the presence (+ lanes, i.e., lanes 5, 7, 9, 11, 13, and 15) or absence ( lanes, i.e., lanes 4, 6, 8, 10, 12, and 14) of a 50-fold excess of unlabeled CPE. Samples were then treated at 4°C with pronase (300 µg) for 5 min (lanes 8 to 11) or 1 h (lanes 12 to 15) or were kept at 4°C without pronase treatment (lanes 4 to 7). All BBMs were then washed with cold DPBS (containing protease inhibitors; see Materials and Methods), extracted with cold DPBS containing 1% Triton X-100 and our standard combination of protease inhibitors, and electrophoresed on a 6% native gel (membrane [Membr.] lanes, i.e., lanes 4, 5, 8, 9, 12, and 13), as described previously (24). Washes from the BBMs were also collected, lyophilized, and electrophoresed on the same gel (Wash lanes, i.e., lanes 6, 7, 10, 11, 14, and 15). Lanes 1 to 3 show free 125I-CPE that was or was not treated with pronase and electrophoresed on the same native gel. Lane 1, 125I-CPE without pronase treatment; lane 2, 125I-CPE treated for 5 min with pronase; lane 3, 125I-CPE treated for 1 h with pronase. Migration of small complex and free 125I-CPE are noted at the left. The gel shown is representative of gels used in six independent repetitions of the experiment. Note that some nonspecific binding samples show significant levels of dye front radioactivity; this result is an artifact due to diffusion of low-Mr radioactive material from gel lanes containing pronase-treated specifically bound radioactivity during the native PAGE used in this experiment (data not shown).

View larger version (69K): [in this window] [in a new window]   FIG. 4.   Native PAGE analysis of pronase-treated Triton X-100 extracts from BBMs containing 125I-CPE bound at 4°C. 125I-CPE was bound to BBMs at 4°C in the absence ( lanes) or the presence (+ lanes) of a 50-fold excess of unlabeled CPE. After the unbound 125I-CPE was removed, BBMs were extracted with cold DPBS containing 1% Triton X-100 and then treated at 4°C with pronase (300 µg) for 5 min (third and fourth lanes) or 1 h (fifth and sixth lanes); the first and second lanes contain samples that were not pronase treated. After the conclusion of pronase treatment, protease inhibitors were added (see Materials and Methods) and all samples were electrophoresed on a native 6% polyacrylamide gel. The migration of small complex is noted at the left. The gel shown is representative of gels used in six independent repetitions of the experiment.

View larger version (68K): [in this window] [in a new window]   FIG. 5.   SDS-PAGE analysis of free 125I-CPE treated with pronase. 125I-CPE (0.15 µg), in the presence of 100 µg of bovine serum albumin, was treated at 4°C with pronase (300 µg) for either 5 min (second lane) or 1 h (third lane) before receiving cold DPBS containing protease inhibitors (see Materials and Methods). These samples were then boiled and electrophoresed on an SDS-10% polyacrylamide gel. For comparison, the first lane shows 125I-CPE that had not been pronase treated. Migrations of molecular mass markers are shown at the right. The gel shown is representative of gels used in 10 independent repetitions of the experiment.

View larger version (68K): [in this window] [in a new window]   FIG. 6.   SDS-PAGE analysis of pronase-treated 125I-CPE bound to BBMs at 4°C. 125I-CPE was bound to BBMs at 4°C, and after removal of unbound 125I-CPE, these samples were either treated for 60 min at 4°C with 300 µg of pronase (lane 1), kept for 60 min at 4°C as an untreated control (lane 2), or subjected to extraction with cold DPBS containing 1% Triton X-100 before treatment for 60 min at 4°C with 300 µg of pronase (lane 3). The lane 1 and 2 samples were washed with cold DPBS containing protease inhibitors (see Materials and Methods) before being subjected to extraction with 1% Triton X-100, while cold DPBS containing similar protease inhibitors were added to the lane 3 sample at the completion of pronase treatment. Each sample was then electrophoresed on preparative native 6% polyacrylamide gel, and samples containing small complex were excised from these gels. Proteins in the excised gel slices were electroeluted, concentrated, treated with urea, boiled, and analyzed on an SDS-12% polyacrylamide gel containing urea. Note that in lane 2 only half the volume of sample was loaded compared to that loaded in lanes 1 and 3. Migrations of molecular mass markers are shown at the right, while the migration of free 125I-CPE is shown at the left. The gel shown is representative of gels used in five independent repetitions of the experiment. Note that the presence of small amounts of intact 125I-CPE in lanes 1 and 3 is not due to spillover, since similar results were observed when these samples were each run on individual gels.

Electrophoretic analysis of pronase-treated ¹²⁵I-CPE bound to BBMs at RT. To confirm that most of the ¹²⁵I-CPE bound to our BBM samples at RT had become localized in large complex, BBMs containing ¹²⁵I-CPE bound at RT were extracted with 1% Triton X-100, and the Triton X-100 extracts were then analyzed with SDS-6% acrylamide gels without -mercaptoethanol treatment or boiling of samples. As expected from previous studies (15, 24), most specifically bound radioactivity in these samples was observed to migrate as a large (~160-kDa) complex (Fig. 7, lane 1). Even washing caused little or no release of this large complex from control (non-pronase-treated) BBMs (Fig. 7, lane 3), which is consistent with Fig. 1B results indicating that ¹²⁵I-CPE that specifically bound at RT shows little or no dissociation.

View larger version (82K): [in this window] [in a new window]   FIG. 7.   SDS-PAGE analysis of pronase-treated 125I-CPE bound to BBMs at RT. 125I-CPE was bound to BBMs at RT in the absence ( lanes, i.e., odd-numbered lanes) or the presence (+ lanes, i.e., even-numbered lanes) of a 50-fold excess of unlabeled CPE. BBMs containing bound 125I-CPE were then treated at 4°C with pronase (300 µg) for 5 min (membrane [Membr.] lanes 5 and 6) or 1 h (Membr. lanes 9 and 10) or were extracted with 1% Triton X-100 before being treated at 4°C with 300 µg of pronase for 5 min (lanes 13 and 14) or 1 h (lanes 15 and 16). Membr. lanes 1 and 2 represent similarly prepared samples that were not treated with pronase. Samples shown in lanes 1, 2, 5, 6, 9, and 10 were washed with cold DPBS containing protease inhibitors (see Materials and Methods) before extraction. Washes (Wash lanes) were collected from all samples and then lyophilized. Lanes 7 and 8 and 11 and 12 contain wash samples collected after 5 min or 1 h of pronase treatment of BBMs, respectively. All samples were then electrophoresed on an SDS-6% polyacrylamide gel without sample boiling or -mercaptoethanol treatment. The migration of intact large complex is noted at the left. The gel shown is representative of gels used in six independent repetitions of the experiment.

View larger version (55K): [in this window] [in a new window]   FIG. 8.   SDS-PAGE analysis (with sample boiling and urea) of pronase-treated 125I-CPE bound to BBMs at RT. 125I-CPE was bound to BBMs at RT, and after removal of unbound 125I-CPE, samples were treated for 60 min at 4°C with 300 µg of pronase (lane 2) or subjected to extraction with 1% Triton X-100 and then treated for 60 min at 4°C with 300 µg of pronase (lane 3). Lane 1 shows a similarly prepared control sample that was kept at 4°C for 60 min without pronase treatment. The samples shown in lanes 1 and 2 were washed with cold DPBS containing protease inhibitors (see Materials and Methods) after pronase treatment, but before Triton X-100 extraction, while cold DPBS containing similar protease inhibitors was added to the lane 3 sample after the conclusion of the pronase treatment. Each sample was then electrophoresed on preparative SDS-6% polyacrylamide gels without sample boiling or -mercaptoethanol treatment. Slices of these preparative gels corresponding to large complex were then excised, and proteins in these gel slices were electroeluted, concentrated, treated with urea, boiled, and electrophoresed on an SDS-15% polyacrylamide gel containing urea. Migrations of molecular mass markers are shown at the right. Migration of 125I-CPE is shown at the left. The gel shown is representative of gels used in five independent repetitions of the experiment.

	DISCUSSION

Top Abstract Introduction Materials & Methods Results Discussion References

Collectively, results presented in this study indicate that, even when it is membrane-associated, CPE localized in small complex is fully susceptible to pronase; however, membranes do offer CPE sequestered in large complex substantial protection from pronase. Although there are other possible explanations for the ability of membranes to protect CPE from pronase when the toxin is localized in large complex, this protective effect is fully consistent with the possibility that a significant portion of the CPE molecule inserts into lipid bilayers after the toxin becomes localized in the large complex. If membrane insertion occurs when CPE is present in large complex and if this inserted CPE can no longer dissociate from BBMs, these factors could help explain the lower rate of spontaneous dissociation of CPE at RT than at 4°C as shown in Fig. 1, since large-complex formation occurs very quickly at RT (15). Further, the new hypothesis proposing that CPE insertion coincides with large-complex formation makes considerably more biologic sense than previous models of CPE action (for a review, see reference 13) that had envisioned an insertion event occurring when CPE is localized in the small complex, given (i) the close association (20) between insertion and the onset of membrane permeability alterations for many other membrane-active bacterial toxins and (ii) observations that CPE-induced membrane permeability alterations develop simultaneously with formation of large complex, not small complex (15, 24).

This study also demonstrates that pronase treatment causes a significant decrease in the size of large complex remaining in washed BBMs. However, our results also indicate that the large complex present in these washed, pronase-treated BBMs still contains substantial amounts of nearly full-sized (i.e., >30-kDa) CPE. Collectively, these observations strongly suggest that much of the decreased size noted for large complex in washed, pronase-treated BBMs is a result of the degradation of one or more of the eucaryotic membrane protein constituents of large complex. Further, the slightly decreased size of CPE present in large complex of pronase-treated BBMs is fully consistent with previous antibody probe results (9) suggesting that at least a portion of the CPE molecule remains surface exposed when this toxin is sequestered in large complex.

While our present results demonstrating that membranes fail to offer CPE localized in small complex any protection from pronase do not support previous hypotheses proposing that insertion occurs when CPE is localized in small complex, some explanation is still needed to explain the limited CPE dissociation that occurs at 4°C. Previous observations (16) indicating that initial interactions between CPE and its receptor are relatively weak suggest that the irreversible membrane association of CPE noted at 4°C does not simply result from a strong receptor-ligand binding affinity. Further, since our observations indicate that the irreversible association of CPE with membranes develops progressively with time after binding at 4°C, this irreversible binding must involve, at least in part, some postbinding change or changes.

One hypothesis involving postbinding changes that may explain the irreversible association of CPE with BBMs at 4°C can be drawn from recent studies (7, 8, 24) that collectively suggest that CPE bound at 4°C may be associated with at least two eucaryotic membrane proteins, i.e., an RVP1 homologue and an ~40- to ~50-kDa protein. Based upon this information, it can be hypothesized that irreversible CPE binding at 4°C might result from the trapping of receptor-bound CPE on the membrane surface, possibly due to one or both of the following postbinding changes: (i) small-complex formation (e.g., perhaps the initial binding of CPE to a receptor is followed by an interaction with a second membrane protein to form small complex; this interaction could effectively trap CPE on the membrane surface) or (ii) a conformational change that occurs soon after small-complex formation (e.g., perhaps CPE simultaneously binds to coreceptors, such as RVP-1 and the 40- to 50-kDa CPE-binding protein [7, 8, 24], to form small complex; this binding could trigger a subsequent conformational change to small complex that traps CPE on the membrane surface). Notably, the possibility that CPE in small complex might be trapped on the membrane surface appears fully consistent with results from this and previous (9) studies indicating that CPE sequestered in small complex remains accessible to both externally applied antibodies and pronase, i.e., at least a portion of CPE remains surface exposed.

Finally, the new information provided by this study can be incorporated into a revised model for CPE action, which involves (i) the binding of CPE to one or more types of receptors; (ii) a postbinding change or changes, possibly involving small-complex formation or a conformational change to small complex, that result in the trapping of CPE on the membrane surface; (iii) a subsequent interaction (which apparently requires membrane diffusion, since it occurs only at warmer temperatures [15]) between this small complex and, possibly, a 70-kDa membrane protein (26) to form large complex; (iv) the large-complex-mediated onset of membrane permeability alterations, which could result from pore formation due to the partial insertion of the CPE molecule (possibly along with one or more eucaryotic proteins present in large complex) when the toxin becomes localized in the large complex; and (v) the breakdown of the cellular osmotic equilibrium, which leads to cell death from lysis or metabolic disturbances. Studies to evaluate this revised model are under way in our laboratory.